Compare MIR & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIR | HTGC |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.2B |
| IPO Year | 2020 | 2004 |
| Metric | MIR | HTGC |
|---|---|---|
| Price | $14.35 | $16.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $24.27 | $19.50 |
| AVG Volume (30 Days) | ★ 3.1M | 1.1M |
| Earning Date | 10-27-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 11.18% |
| EPS Growth | ★ 161.11 | 14.91 |
| EPS | 0.02 | ★ 0.90 |
| Revenue | N/A | N/A |
| Revenue This Year | $23.19 | $9.32 |
| Revenue Next Year | $7.31 | $7.07 |
| P/E Ratio | $713.00 | ★ $18.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.11 | $13.70 |
| 52 Week High | $30.28 | $19.13 |
| Indicator | MIR | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 38.79 |
| Support Level | $14.17 | $16.37 |
| Resistance Level | $16.38 | $17.15 |
| Average True Range (ATR) | 0.60 | 0.29 |
| MACD | -0.23 | -0.10 |
| Stochastic Oscillator | 3.69 | 9.77 |
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.